GO
Loading...

Acquisitions

More

  • UPDATE 2-Cobham to buy U.S. firm Aeroflex for $920 mln Tuesday, 20 May 2014 | 12:04 PM ET

    *To pay $10.50 per Aeroflex share, 26 pct above Monday close. LONDON, May 20- British aerospace and defence supplier Cobham is buying U.S. communications equipment maker Aeroflex Holding Corp for $920 million, continuing its quest for commercial customers as its main defence clients cut spending.

  • *Schroders urges AstraZeneca to restart talks with Pfizer. LONDON, May 20- Schroders, AstraZeneca's 12th- biggest shareholder, urged the drugmaker to restart takeover talks with Pfizer as rival Fidelity, ranking 18th, backed the British company's stance.

  • LONDON, May 20- AstraZeneca shareholder Schroders urged the company to restart takeover talks with Pfizer, adding its voice to criticism of the British drugmaker's rejection of the U.S. firm's 70 billion pound bid. Schroders is AstraZeneca's twelfth-largest shareholder with a 2 percent stake.

  • *To pay $10.50 per Aeroflex share, 26 pct above Mon close. LONDON, May 20- British aerospace and defence supplier Cobham is buying U.S. communications equipment maker Aeroflex Holding Corp for $1.46 billion, continuing its quest for more commercial customers as its main defence clients cut spending.

  • SYDNEY, May 20- Australia's Treasury Wine Estates, the world's second biggest winemaker by sales, said it rejected a A $3.1 billion takeover offer from private equity giant Kohlberg Kravis Roberts& Co LP on the grounds that it was too low.

  • LONDON, May 19- U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.

  • Google in talks to buy Twitch     Monday, 19 May 2014 | 12:55 PM ET

    YouTube is reportedly ready to make its largest acquisition ever. CNBC's Josh Lipton provides insight to the potential deal.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • May 19- Activist investor William Ackman said on Monday in a letter to takeover target Allergan Inc's board of directors that the top executive has a "disabling" conflict of interest because accepting a takeover means losing the top job.

  • *AstraZeneca slumps after rejecting "final" Pfizer bid. LONDON, May 19- European equities slid on Monday, pulled down by pharmaceuticals group AstraZeneca, which slumped after rejecting a Pfizer takeover bid, and by Deutsche Bank, where a capital increase weighed on bank stocks.

  • LONDON, May 19- U.S. drugmaker Pfizer is likely to court major investors in AstraZeneca as part of a takeover attempt despite a board rejection of its 70 billion pounds bid, the head of Britain's parliamentary science committee said.

  • May 18- AT&T plans to pay $48.5 billion to buy DirecTV, the top U.S. satellite TV operator, in a bid for growth beyond an increasingly competitive cellular market. AT&T said it is offering $95 per DirecTV share in a combination of stock and cash, a 10 percent premium over Friday's closing price of $86.18.

  • May 18- DirecTV, the No. 1 U.S. satellite TV operator, said on Sunday it has agreed to sell itself to AT&T for $48.5 billion, in the second mega-deal to shake up the U.S. television landscape this year. AT&T said it is offering $95 per DirecTV share in a combination of stock and cash, a 10 percent premium over Friday's closing price of $86.18.

  • LONDON, May 18- U.S. drugmaker Pfizer Inc is planning to raise its offer for AstraZeneca Plc as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.

  • Clock ticking for Pfizer to raise AstraZeneca bid Sunday, 18 May 2014 | 8:30 AM ET

    LONDON, May 18- Pfizer is considering raising its offer for AstraZeneca as it works with its advisers against the clock in a battle where they have just eight days left to move under British takeover rules.

  • AstraZeneca arrays academic assets in Pfizer defence Sunday, 18 May 2014 | 6:21 AM ET

    CAMBRIDGE, England, May 18- Rising up from the fields around the university city of Cambridge, the steel towers of the Laboratory of Molecular Biology, are scientific pillars in the defence that drugs group AstraZeneca is mounting against a takeover approach by its U.S. rival Pfizer.

  • AstraZeneca arrays academic assets in Pfizer defense Sunday, 18 May 2014 | 6:21 AM ET

    CAMBRIDGE, England, May 18- Rising up from the fields around the university city of Cambridge, the steel towers of the Laboratory of Molecular Biology, are scientific pillars in the defense that drugs group AstraZeneca is mounting against a takeover approach by its U.S. rival Pfizer.

  • NEW YORK May 17- AT&T is close to announcing that it will buy the No. 1 U.S. satellite TV operator DirecTV, according to people familiar with the matter, in the second potentially transformative deal to jolt the U.S. television industry this year.

  • May 16- Abbott Laboratories said on Friday it would acquire Chile's CFR Pharmaceuticals SA in a two-part, $2.9 billion deal, to double its branded generic drugs portfolio and expand in the fast-growing Latin American market.

  • PARIS/ LONDON, May 16- French telecoms market leader Orange is in talks about a tie-up with Bouygues Telecom, France's economy minister said on Friday after two sources said the discussions could lead to Orange acquiring its smaller rival.